SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nascimento Egidio

(Last)

(First)

(Middle)

C/O VBI VACCINES INC.

222 THIRD STREET, STE 2241

(Street)

CAMBRIDGE

02142

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/25/2014

3. Issuer Name and Ticker or Trading Symbol
VBI VACCINES INC. [ VBIV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,411	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	⁽¹⁾	12/22/2016	Common Stock	26,818	$1.3	D
Stock Option	⁽²⁾	03/18/2018	Common Stock	8,981	$1.3	D
Stock Option	⁽³⁾	01/21/2019	Common Stock	25,988	$2.65	D
Stock Option	⁽⁴⁾	03/29/2022	Common Stock	10,298	$1.3	D
Stock Option	⁽⁵⁾	04/02/2022	Common Stock	10,298	$1.3	D
Stock Option	⁽⁶⁾	04/24/2024	Common Stock	294,317	$2.15	D

Explanation of Responses:

1. 26,818 options vest according to the following schedule: 1/48 per month following the grant date of December 22, 2006.

2. 8,981 options vest according to the following schedule: 1/48 per month following the grant date of March 18, 2008.

3. 25,988 options vest according to the following schedule: 1/48 per month following the grant date of January 21, 2009.

4. 10,298 options vest according to the following schedule: 1/48 per month following the grant date of March 29, 2012.

5. 10,298 options vest according to the following schedule: 1/48 per month following the grant date of April 2, 2012.

6. 294,317 options vest according to the following schedule: 1/48 per month following the grant date of April 24, 2014.

	/s/ Egidio Nascimento	08/01/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.